Showing results (21-30 of 77) with videos related to
Sort By:
Pageof 8
Glycobiology|July 20, 2010
Production of non-fucosylated antibodies by co-expression of heterologous GDP-6-deoxy-D-lyxo-4-hexulose reductaseHans Henning von Horsten, Christiane Ogorek, Véronique Blanchard, et al.Cureus|September 30, 2022
An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 VaccinationTibor Bakacs, Volker Sandig, Imre KovesdiPharmaceuticals (Basel, Switzerland)|June 1, 2023
Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and AcyclovirTibor Bakacs, Volker Sandig, Imre KovesdiAvian Pathology : Journal of the W.V.P.A|January 28, 2016
Continuous cell lines from the Muscovy duck as potential replacement for primary cells in the production of avian vaccinesIngo Jordan, Katrin John, Kristin Höwing, et al.Vaccines|July 27, 2024
Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika VaccineSven Göbel, Ozeir Kazemi, Ji Ma, et al.Journal of Bioscience and Bioengineering|August 26, 2011
Metabolite channeling and compartmentation in the human cell line AGE1.HN determined by 13C labeling experiments and 13C metabolic flux analysisJens Niklas, Volker Sandig, Elmar HeinzleFrontiers in Immunology|February 21, 2024
Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passagesPatrick Neckermann, Madlen Mohr, Martina Billmeier, et al.Vaccines|July 30, 2025
Optimization of YF17D-Vectored Zika Vaccine Production by Employing Small-Molecule Viral Sensitizers to Enhance YieldsSven Göbel, Tilia Zinnecker, Ingo Jordan, et al.Virology|May 3, 2003
The complete nucleotide sequence, genome organization, and origin of human adenovirus type 11Daniel Stone, Anne Furthmann, Volker Sandig, et al.Biologicals : Journal of the International Association of Biological Standardization|January 18, 2011
A chemically defined production process for highly attenuated poxvirusesIngo Jordan, Stefan Northoff, Michael Thiele, et al.Pageof 8